glp-1-based therapies UC Davis Health examines systemic impact of GLP-1–based Insights into incretin-based therapies for
Description
Obesity is a fibroblast growth factor 21 (FGF21)-resistant state
If you experience worsening depression or anxiety after starting GLP-1 therapy, contact your psychiatrist or primary care provider immediately
The cardioprotective effects of GLP-1 RAs are thought to arise from their pleiotropic effects [49]
but that was not affected by EMPA alone (Fig
Combining medication with other strategies improves long-term success
